[S02DA03, antipyrine, The metabolism of Antipyrine can be decreased when combined with Epinephrine.]
[J01EC02, sulfadiazine, The therapeutic efficacy of Sulfadiazine can be decreased when used in combination with Epinephrine.]
[J01EC01, sulfamethoxazole, The therapeutic efficacy of Sulfamethoxazole can be decreased when used in combination with Epinephrine.]
[S01AB02, sulfisoxazole, The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Epinephrine.]
[M01AB02, sulindac, The risk or severity of hypertension can be increased when Sulindac is combined with Epinephrine.]
[A10BB04, glibornuride, The therapeutic efficacy of Glibornuride can be decreased when used in combination with Epinephrine.]
[A10BC01, glymidine, The therapeutic efficacy of Glymidine can be decreased when used in combination with Epinephrine.]
[M01AX04, apazone, The risk or severity of hypertension can be increased when Epinephrine is combined with Azapropazone.]
[L01BB02, mercaptopurine, The risk or severity of adverse effects can be increased when Epinephrine is combined with Mercaptopurine.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Epinephrine.]
[L01CB02, teniposide, The metabolism of Teniposide can be decreased when combined with Epinephrine.]
[R03CC03, terbutaline, The therapeutic efficacy of Terbutaline can be increased when used in combination with Epinephrine.]
[G03BA03, testosterone, The metabolism of Testosterone can be decreased when combined with Epinephrine.]
[N05AE05, lurasidone, Epinephrine may increase the hypotensive activities of Lurasidone.]
[A04AD10, dronabinol, The serum concentration of Dronabinol can be increased when it is combined with Epinephrine.]
[L04AX02, thalidomide, The metabolism of Thalidomide can be decreased when combined with Epinephrine.]
[R03DA07, theobromine, The risk or severity of adverse effects can be increased when Epinephrine is combined with Theobromine.]
[R03DA04, theophylline, The metabolism of Theophylline can be decreased when combined with Epinephrine.]
[A11DA01, thiamine, The serum concentration of Epinephrine can be increased when it is combined with Thiamine.]
[R06AD03, thiethylperazine, The therapeutic efficacy of Epinephrine can be increased when used in combination with Thiethylperazine.]
[L01AC01, thiotepa, The metabolism of Thiotepa can be decreased when combined with Epinephrine.]
[N05AB08, thioproperazine, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Thioproperazine.]
[N05AC02, thioridazine, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Thioridazine.]
[G04BE06, moxisylyte, Moxisylyte may decrease the hypertensive activities of Epinephrine.]
[V04CJ01, thyrotropin, The risk or severity of adverse effects can be increased when Epinephrine is combined with Thyrotropin.]
[V04CJ02, thyrotropin-releasing hormone, The risk or severity of adverse effects can be increased when Epinephrine is combined with Protirelin.]
[S01ED01, timolol, Timolol may decrease the bronchodilatory activities of Epinephrine.]
[A10BB05, tolazamide, The therapeutic efficacy of Tolazamide can be decreased when used in combination with Epinephrine.]
[M02AX02, tolazoline, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Tolazoline.]
[V04CA01, tolbutamide, The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Epinephrine.]
[M02AA21, tolmetin, The risk or severity of hypertension can be increased when Tolmetin is combined with Epinephrine.]
[N02AX02, tramadol, The metabolism of Tramadol can be decreased when combined with Epinephrine.]
[N06AF04, tranylcypromine, Tranylcypromine may increase the hypertensive activities of Epinephrine.]
[N06AX05, trazodone, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Trazodone.]
[L01XF01, tretinoin, The metabolism of Tretinoin can be decreased when combined with Epinephrine.]
[S01BA05, triamcinolone, The risk or severity of hypokalemia can be increased when Triamcinolone is combined with Epinephrine.]
[C03DB02, triamterene, The risk or severity of Cardiac Arrhythmia can be increased when Epinephrine is combined with Triamterene.]
[C03AA06, trichlormethiazide, The risk or severity of hypokalemia can be increased when Epinephrine is combined with Trichlormethiazide.]
[A03AB12, mepenzolate, The risk or severity of Tachycardia can be increased when Epinephrine is combined with Mepenzolate.]
[N05AB06, trifluoperazine, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Trifluoperazine.]
[N05AA05, triflupromazine, The risk or severity of Tachycardia can be increased when Triflupromazine is combined with Epinephrine.]
[D07AC02, fluclorolone, The risk or severity of hypokalemia can be increased when Fluclorolone is combined with Epinephrine.]
[N04AA01, trihexyphenidyl, The risk or severity of Tachycardia can be increased when Trihexyphenidyl is combined with Epinephrine.]
[R03BA07, mometasone, The risk or severity of hypokalemia can be increased when Mometasone is combined with Epinephrine.]
[A03AA05, trimebutine, The risk or severity of Tachycardia can be increased when Epinephrine is combined with Trimebutine.]
[R06AD01, trimeprazine, The therapeutic efficacy of Epinephrine can be increased when used in combination with Alimemazine.]
[N03AC02, trimethadione, The metabolism of Trimethadione can be decreased when combined with Epinephrine.]
[C02BA01, trimethaphan, Epinephrine may decrease the antihypertensive activities of Trimethaphan.]
[J01EA01, trimethoprim, The serum concentration of Epinephrine can be increased when it is combined with Trimethoprim.]
[N06AA06, trimipramine, The metabolism of Trimipramine can be decreased when combined with Epinephrine.]
[R06AC04, tripelennamine, The therapeutic efficacy of Epinephrine can be increased when used in combination with Tripelennamine.]
[R06AX07, triprolidine, The therapeutic efficacy of Epinephrine can be increased when used in combination with Triprolidine.]
[A03BB01, butylscopolamine, The risk or severity of Tachycardia can be increased when Epinephrine is combined with Butylscopolamine.]
[N06AX24, vilazodone, The risk or severity of hypertension can be increased when Epinephrine is combined with Vilazodone.]
[C09CA09, azilsartan medoxomil, Epinephrine may decrease the antihypertensive activities of Azilsartan medoxomil.]
[R03DX07, roflumilast, The serum concentration of Roflumilast can be increased when it is combined with Epinephrine.]
[L01EX04, vandetanib, The metabolism of Vandetanib can be decreased when combined with Epinephrine.]
[A10BH05, linagliptin, The therapeutic efficacy of Linagliptin can be decreased when used in combination with Epinephrine.]
[R03AC18, indacaterol, The risk or severity of adverse effects can be increased when Epinephrine is combined with Indacaterol.]
[C08DA01, verapamil, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Verapamil.]
[L01CA01, vinblastine, The metabolism of Vinblastine can be decreased when combined with Epinephrine.]
[C04AX07, vincamine, Epinephrine may decrease the antihypertensive activities of Vincamine.]
[L01CA02, vincristine, The metabolism of Vincristine can be decreased when combined with Epinephrine.]
[L01CA03, vindesine, The metabolism of Vindesine can be decreased when combined with Epinephrine.]
[B01AA03, warfarin, The serum concentration of Warfarin can be increased when it is combined with Epinephrine.]
[N01AX15, xenon, Xenon may increase the arrhythmogenic activities of Epinephrine.]
[C03BA10, xipamide, The risk or severity of Cardiac Arrhythmia can be increased when Epinephrine is combined with Xipamide.]
[J05AF01, zidovudine, The metabolism of Zidovudine can be decreased when combined with Epinephrine.]
[N05AF05, zuclopenthixol, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Zuclopenthixol.]
[J05AE02, indinavir, The risk or severity of adverse effects can be increased when Indinavir is combined with Epinephrine.]
[L01EC01, vemurafenib, The metabolism of Vemurafenib can be decreased when combined with Epinephrine.]
[L01FX05, brentuximab vedotin, The metabolism of Brentuximab vedotin can be decreased when combined with Epinephrine.]
[L01ED01, crizotinib, The metabolism of Crizotinib can be decreased when combined with Epinephrine.]
[R03DC01, zafirlukast, The metabolism of Zafirlukast can be decreased when combined with Epinephrine.]
[N05AE04, ziprasidone, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Ziprasidone.]
[G03AC10, drospirenone, The metabolism of Drospirenone can be decreased when combined with Epinephrine.]
[N02BA01, aspirin, The metabolism of Acetylsalicylic acid can be decreased when combined with Epinephrine.]
[L01EJ01, ruxolitinib, The metabolism of Ruxolitinib can be decreased when combined with Epinephrine.]
[G04BD07, tolterodine, The metabolism of Tolterodine can be decreased when combined with Epinephrine.]
[C07AB03, atenolol, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Atenolol.]
[J02AC03, voriconazole, The metabolism of Voriconazole can be decreased when combined with Epinephrine.]
[S01FA01, atropine, The risk or severity of hypertension can be increased when Atropine is combined with Epinephrine.]
[L01XJ01, vismodegib, The metabolism of Vismodegib can be decreased when combined with Epinephrine.]
[L01EK01, axitinib, The metabolism of Axitinib can be decreased when combined with Epinephrine.]
[H02AB11, prednylidene, The risk or severity of hypokalemia can be increased when Prednylidene is combined with Epinephrine.]
[G04BE10, avanafil, The metabolism of Avanafil can be decreased when combined with Epinephrine.]
[G04BD12, mirabegron, The risk or severity of hypertension can be increased when Epinephrine is combined with Mirabegron.]
[L02BB04, enzalutamide, The serum concentration of Enzalutamide can be increased when it is combined with Epinephrine.]
[L01EA04, bosutinib, The metabolism of Bosutinib can be decreased when combined with Epinephrine.]
[C01CA18, octopamine, The risk or severity of hypertension can be increased when Epinephrine is combined with Octopamine.]
[H02AA01, aldosterone, The risk or severity of hypokalemia can be increased when Aldosterone is combined with Epinephrine.]
[L01EX05, regorafenib, The metabolism of Regorafenib can be decreased when combined with Epinephrine.]
[C01AA01, acetyldigitoxin, The risk or severity of Cardiac Arrhythmia can be increased when Epinephrine is combined with Acetyldigitoxin.]
[J05AE04, nelfinavir, The risk or severity of adverse effects can be increased when Nelfinavir is combined with Epinephrine.]
[N04BD02, rasagiline, Rasagiline may increase the hypertensive activities of Epinephrine.]
[C08CA13, lercanidipine, Epinephrine may decrease the antihypertensive activities of Lercanidipine.]
[N06DA02, donepezil, The metabolism of Donepezil can be decreased when combined with Epinephrine.]
[L04AA29, tofacitinib, The metabolism of Tofacitinib can be decreased when combined with Epinephrine.]
[N02CC03, zolmitriptan, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Epinephrine.]
[R06AC06, thonzylamine, The therapeutic efficacy of Epinephrine can be increased when used in combination with Thonzylamine.]
[G04BD10, darifenacin, The risk or severity of Tachycardia can be increased when Darifenacin is combined with Epinephrine.]
[N01AA01, ethyl ether, Diethyl ether may increase the arrhythmogenic activities of Epinephrine.]
[L01EX07, cabozantinib, The metabolism of Cabozantinib can be decreased when combined with Epinephrine.]
[G04BE03, sildenafil, The metabolism of Sildenafil can be decreased when combined with Epinephrine.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Epinephrine.]
[B01AF02, apixaban, The metabolism of Apixaban can be decreased when combined with Epinephrine.]
[C10AX12, lomitapide, The metabolism of Lomitapide can be decreased when combined with Epinephrine.]
[A10BH04, alogliptin, The therapeutic efficacy of Alogliptin can be decreased when used in combination with Epinephrine.]
[C03AA01, bendroflumethiazide, The risk or severity of hypokalemia can be increased when Epinephrine is combined with Bendroflumethiazide.]
[L04AX06, pomalidomide, The metabolism of Pomalidomide can be decreased when combined with Epinephrine.]
[G03XC05, ospemifene, The metabolism of Ospemifene can be decreased when combined with Epinephrine.]
[N02BA10, benorilate, The risk or severity of hypertension can be increased when Epinephrine is combined with Benorilate.]
[A10BK02, canagliflozin, The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Epinephrine.]
[H03AA04, tiratricol, The risk or severity of adverse effects can be increased when Epinephrine is combined with Tiratricol.]
[A10AE05, insulin detemir, The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Epinephrine.]
[A10BX05, pramlintide, The therapeutic efficacy of Pramlintide can be decreased when used in combination with Epinephrine.]
[M01AH01, celecoxib, The metabolism of Celecoxib can be decreased when combined with Epinephrine.]
[N02CC02, naratriptan, The risk or severity of hypertension can be increased when Epinephrine is combined with Naratriptan.]
[L04AA18, everolimus, The metabolism of Everolimus can be decreased when combined with Epinephrine.]
[N04AC01, benztropine, The risk or severity of Tachycardia can be increased when Benzatropine is combined with Epinephrine.]
[L01EC02, dabrafenib, The metabolism of Dabrafenib can be decreased when combined with Epinephrine.]
[R02AX03, benzydamine, The risk or severity of hypertension can be increased when Epinephrine is combined with Benzydamine.]
[H05AA03, parathyroid hormone, The risk or severity of adverse effects can be increased when Epinephrine is combined with Parathyroid hormone.]
[N06AX28, levomilnacipran, Levomilnacipran may increase the tachycardic activities of Epinephrine.]
[J05AJ03, dolutegravir, The serum concentration of Epinephrine can be increased when it is combined with Dolutegravir.]
[C08EA02, bepridil, Epinephrine may decrease the antihypertensive activities of Bepridil.]
[C02KX05, riociguat, Epinephrine may decrease the antihypertensive activities of Riociguat.]
[A10BJ03, lixisenatide, The therapeutic efficacy of Lixisenatide can be decreased when used in combination with Epinephrine.]
[C02KX04, macitentan, Epinephrine may decrease the antihypertensive activities of Macitentan.]
[L01EL01, ibrutinib, The metabolism of Ibrutinib can be decreased when combined with Epinephrine.]
[N06AX26, vortioxetine, The metabolism of Vortioxetine can be decreased when combined with Epinephrine.]
[A10BK01, dapagliflozin, The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Epinephrine.]
[C01CA27, droxidopa, The therapeutic efficacy of Epinephrine can be increased when used in combination with Droxidopa.]
[C07AB04, acebutolol, The therapeutic efficacy of Acebutolol can be increased when used in combination with Epinephrine.]
[N05CH03, tasimelteon, The metabolism of Tasimelteon can be decreased when combined with Epinephrine.]
[N07CA01, betahistine, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Betahistine.]
[S03BA03, betamethasone, The risk or severity of hypokalemia can be increased when Betamethasone is combined with Epinephrine.]
[S01ED02, betaxolol, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Betaxolol.]
[C02CC01, bethanidine, Epinephrine may decrease the antihypertensive activities of Bethanidine.]
[A10BJ04, albiglutide, The therapeutic efficacy of Albiglutide can be decreased when used in combination with Epinephrine.]
[L01ED02, ceritinib, The metabolism of Ceritinib can be decreased when combined with Epinephrine.]
[B01AC26, vorapaxar, The metabolism of Vorapaxar can be decreased when combined with Epinephrine.]
[A03BA03, hyoscyamine, The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Epinephrine.]
[B01AA07, acenocoumarol, The serum concentration of Acenocoumarol can be increased when it is combined with Epinephrine.]
[L01EM01, idelalisib, The metabolism of Idelalisib can be decreased when combined with Epinephrine.]
[A10BK03, empagliflozin, The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Epinephrine.]
[R03AC19, olodaterol, The risk or severity of adverse effects can be increased when Epinephrine is combined with Olodaterol.]
[D11AA01, glycopyrronium, The risk or severity of Tachycardia can be increased when Epinephrine is combined with Glycopyrronium.]
[N05CM19, suvorexant, The metabolism of Suvorexant can be decreased when combined with Epinephrine.]
[A16AX10, eliglustat, The metabolism of Eliglustat can be decreased when combined with Epinephrine.]
[N05AA04, acepromazine, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Acepromazine.]
[V04CX03, methacholine, Epinephrine may decrease effectiveness of Methacholine as a diagnostic agent.]
[A10BJ05, dulaglutide, The therapeutic efficacy of Dulaglutide can be decreased when used in combination with Epinephrine.]
[N04AA02, biperiden, The risk or severity of Tachycardia can be increased when Epinephrine is combined with Biperiden.]
[L04AX05, pirfenidone, The metabolism of Pirfenidone can be decreased when combined with Epinephrine.]
[L01EX09, nintedanib, The metabolism of Nintedanib can be decreased when combined with Epinephrine.]
[S03AA06, gentamicin, The serum concentration of Gentamicin can be increased when it is combined with Epinephrine.]
[L01XK01, olaparib, The metabolism of Olaparib can be decreased when combined with Epinephrine.]
[B01AA01, dicumarol, The metabolism of Dicoumarol can be decreased when combined with Epinephrine.]
[N06AX11, mirtazapine, Mirtazapine may decrease the antihypertensive activities of Epinephrine.]
[L01EF01, palbociclib, The metabolism of Palbociclib can be decreased when combined with Epinephrine.]
[L01EX08, lenvatinib, The serum concentration of Epinephrine can be increased when it is combined with Lenvatinib.]
[L01XH03, panobinostat, The metabolism of Panobinostat can be decreased when combined with Epinephrine.]
[A03AA09, difemerine, The risk or severity of Tachycardia can be increased when Epinephrine is combined with Difemerine.]
[J05AP06, asunaprevir, The metabolism of Asunaprevir can be decreased when combined with Epinephrine.]
[N05AX16, brexpiprazole, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Brexpiprazole.]
[L01XJ02, sonidegib, The metabolism of Sonidegib can be decreased when combined with Epinephrine.]
[G02CX02, flibanserin, The risk or severity of hypertension can be increased when Epinephrine is combined with Flibanserin.]
[N05AX15, cariprazine, The risk or severity of hypertension can be increased when Epinephrine is combined with Cariprazine.]
[A10BF01, acarbose, The therapeutic efficacy of Acarbose can be decreased when used in combination with Epinephrine.]
[M02AA25, aceclofenac, The risk or severity of hypertension can be increased when Epinephrine is combined with Aceclofenac.]
[M01AB11, acemetacin, The risk or severity of hypertension can be increased when Epinephrine is combined with Acemetacin.]
[S01EC01, acetazolamide, The risk or severity of Cardiac Arrhythmia can be increased when Epinephrine is combined with Acetazolamide.]
[A10AE06, insulin degludec, The therapeutic efficacy of Insulin degludec can be decreased when used in combination with Epinephrine.]
[A02BC03, lansoprazole, The metabolism of Lansoprazole can be decreased when combined with Epinephrine.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Epinephrine.]
[J02AC05, isavuconazole, The serum concentration of Epinephrine can be increased when it is combined with Isavuconazole.]
[L01EB04, osimertinib, The metabolism of Osimertinib can be decreased when combined with Epinephrine.]
[J05AF13, tenofovir alafenamide, The metabolism of Tenofovir alafenamide can be decreased when combined with Epinephrine.]
[L01EE02, cobimetinib, The metabolism of Cobimetinib can be decreased when combined with Epinephrine.]
[L01XG03, ixazomib, The metabolism of Ixazomib can be decreased when combined with Epinephrine.]
[L01ED03, alectinib, The metabolism of Alectinib can be decreased when combined with Epinephrine.]
[B01AC27, selexipag, Epinephrine may decrease the antihypertensive activities of Selexipag.]
[A10BB31, acetohexamide, The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Epinephrine.]
[G04CA01, alfuzosin, The metabolism of Alfuzosin can be decreased when combined with Epinephrine.]
[M04AB05, lesinurad, The metabolism of Lesinurad can be decreased when combined with Epinephrine.]
[M01AE16, alminoprofen, The risk or severity of hypertension can be increased when Epinephrine is combined with Alminoprofen.]
[N03AX23, brivaracetam, The metabolism of Brivaracetam can be decreased when combined with Epinephrine.]
[L01XX52, venetoclax, The metabolism of Venetoclax can be decreased when combined with Epinephrine.]
[N04BC01, bromocriptine, Bromocriptine may increase the hypertensive and vasoconstricting activities of Epinephrine.]
[R06AB01, brompheniramine, The therapeutic efficacy of Epinephrine can be increased when used in combination with Dexbrompheniramine.]
[N06AA19, amineptin, Amineptine may increase the vasopressor activities of Epinephrine.]
[C08CA01, amlodipine, Epinephrine may decrease the antihypertensive activities of Amlodipine.]
[N05AX17, pimavanserin, The metabolism of Pimavanserin can be decreased when combined with Epinephrine.]
[C03CA02, bumetanide, The risk or severity of hypokalemia can be increased when Epinephrine is combined with Bumetanide.]
[C07AA19, bupranolol, Bupranolol may decrease the bronchodilatory activities of Epinephrine.]
[N07BC01, buprenorphine, The metabolism of Buprenorphine can be decreased when combined with Epinephrine.]
[N05BE01, buspirone, The risk or severity of hypertension can be increased when Buspirone is combined with Epinephrine.]
[L01AB01, busulfan, The metabolism of Busulfan can be decreased when combined with Epinephrine.]
[P01BE02, artemether, The metabolism of Artemether can be decreased when combined with Epinephrine.]
[R06AX09, azatadine, The therapeutic efficacy of Epinephrine can be increased when used in combination with Azatadine.]
[S01GX07, azelastine, The metabolism of Azelastine can be decreased when combined with Epinephrine.]
[S01AA26, azithromycin, The metabolism of Azithromycin can be decreased when combined with Epinephrine.]
[L01EF02, ribociclib, The metabolism of Ribociclib can be decreased when combined with Epinephrine.]
[A07EC04, balsalazide, The risk or severity of hypertension can be increased when Epinephrine is combined with Balsalazide.]
[R03CC12, bambuterol, The risk or severity of adverse effects can be increased when Epinephrine is combined with Bambuterol.]
[R03DA08, bamifylline, The risk or severity of adverse effects can be increased when Epinephrine is combined with Bamifylline.]
[N06BC01, caffeine, The risk or severity of adverse effects can be increased when Epinephrine is combined with Caffeine.]
[C09AA07, benazepril, Epinephrine may decrease the antihypertensive activities of Benazepril.]
[A10BX06, benfluorex, The therapeutic efficacy of Benfluorex can be decreased when used in combination with Epinephrine.]
[J01XX08, linezolid, The risk or severity of hypertension can be increased when Linezolid is combined with Epinephrine.]
[H03BA03, benzylthiouracil, The risk or severity of adverse effects can be increased when Epinephrine is combined with Benzylthiouracil.]
[L01EX10, midostaurin, The metabolism of Midostaurin can be decreased when combined with Epinephrine.]
[H05AA04, abaloparatide, The risk or severity of adverse effects can be increased when Epinephrine is combined with Abaloparatide.]
[L01ED04, brigatinib, The metabolism of Brigatinib can be decreased when combined with Epinephrine.]
[N04BD03, safinamide, Safinamide may increase the hypertensive activities of Epinephrine.]
[L01BC06, capecitabine, The metabolism of Capecitabine can be decreased when combined with Epinephrine.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Epinephrine.]
[L01EH02, neratinib, The metabolism of Neratinib can be decreased when combined with Epinephrine.]
[L01EM02, copanlisib, The metabolism of Copanlisib can be decreased when combined with Epinephrine.]
[L01EF03, abemaciclib, The metabolism of Abemaciclib can be decreased when combined with Epinephrine.]
[C07AB07, bisoprolol, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Bisoprolol.]
[R03AC17, bitolterol, The risk or severity of adverse effects can be increased when Epinephrine is combined with Bitolterol.]
[J05AG03, efavirenz, The risk or severity of adverse effects can be increased when Efavirenz is combined with Epinephrine.]
[C07AA17, bopindolol, Bopindolol may decrease the bronchodilatory activities of Epinephrine.]
[N04AA11, bornaprine, The risk or severity of Tachycardia can be increased when Epinephrine is combined with Bornaprine.]
[C03DA03, canrenone, The risk or severity of Cardiac Arrhythmia can be increased when Epinephrine is combined with Canrenone.]
[R03BA02, budesonide, The risk or severity of hypokalemia can be increased when Budesonide is combined with Epinephrine.]
[C04AX20, buflomedil, Buflomedil may decrease the hypertensive activities of Epinephrine.]
[M01AB07, bumadizone, The risk or severity of hypertension can be increased when Epinephrine is combined with Bumadizone.]
[L01EL02, acalabrutinib, The metabolism of Acalabrutinib can be decreased when combined with Epinephrine.]
[N06AA15, butriptyline, Butriptyline may increase the vasopressor activities of Epinephrine.]
[C01AA02, acetyldigoxins, The risk or severity of Cardiac Arrhythmia can be increased when Epinephrine is combined with Acetyldigoxin.]
[A10BJ06, semaglutide, The therapeutic efficacy of Semaglutide can be decreased when used in combination with Epinephrine.]
[A10BK04, ertugliflozin, The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Epinephrine.]
[R06AX18, acrivastine, The therapeutic efficacy of Epinephrine can be increased when used in combination with Acrivastine.]
[C09AA01, captopril, Epinephrine may decrease the antihypertensive activities of Captopril.]
[L02BB05, apalutamide, The serum concentration of Epinephrine can be increased when it is combined with Apalutamide.]
[N03AF01, carbamazepine, The metabolism of Carbamazepine can be decreased when combined with Epinephrine.]
[A03AA03, camylofine, The risk or severity of Tachycardia can be increased when Epinephrine is combined with Camylofin.]
[H03BB01, carbimazole, The risk or severity of adverse effects can be increased when Epinephrine is combined with Carbimazole.]
[R06AA08, carbinoxamine, The therapeutic efficacy of Epinephrine can be increased when used in combination with Carbinoxamine.]
[C07AG02, carvedilol, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Carvedilol.]
[N03AX24, cannabidiol, The metabolism of Cannabidiol can be decreased when combined with Epinephrine.]
[C07AB08, celiprolol, The therapeutic efficacy of Celiprolol can be increased when used in combination with Epinephrine.]
[L01XX62, ivosidenib, The metabolism of Ivosidenib can be decreased when combined with Epinephrine.]
[P01BA07, tafenoquine, The serum concentration of Epinephrine can be increased when it is combined with Tafenoquine.]
[L01EM04, duvelisib, The metabolism of Duvelisib can be decreased when combined with Epinephrine.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be decreased when combined with Epinephrine.]
[S01GX12, cetirizine, The therapeutic efficacy of Epinephrine can be increased when used in combination with Cetirizine.]
[A10BB06, carbutamide, The therapeutic efficacy of Carbutamide can be decreased when used in combination with Epinephrine.]
[N01BA04, chloroprocaine, The risk or severity of adverse effects can be increased when Epinephrine is combined with Chloroprocaine.]
[R06AC03, chloropyramine, The therapeutic efficacy of Epinephrine can be increased when used in combination with Chloropyramine.]
[R06AA06, chlorphenoxamine, The therapeutic efficacy of Epinephrine can be increased when used in combination with Chlorphenoxamine.]
[M01AC05, lornoxicam, The metabolism of Lornoxicam can be decreased when combined with Epinephrine.]
[R03DA02, oxtriphylline, The risk or severity of adverse effects can be increased when Epinephrine is combined with Oxtriphylline.]
[L01EX13, gilteritinib, The metabolism of Gilteritinib can be decreased when combined with Epinephrine.]
[A06AX05, prucalopride, The metabolism of Prucalopride can be decreased when combined with Epinephrine.]
[C09AA08, cilazapril, Epinephrine may decrease the antihypertensive activities of Cilazapril.]
[B01AC23, cilostazol, The metabolism of Cilostazol can be decreased when combined with Epinephrine.]
[A03FA08, cinitapride, The risk or severity of hypertension can be increased when Epinephrine is combined with Cinitapride.]
[P02BX04, triclabendazole, The metabolism of Triclabendazole can be decreased when combined with Epinephrine.]
[N06AX27, esketamine, The risk or severity of hypertension can be increased when Esketamine is combined with Epinephrine.]
[L04AA42, siponimod, The metabolism of Siponimod can be decreased when combined with Epinephrine.]
[N06BA14, solriamfetol, The risk or severity of hypertension can be increased when Solriamfetol is combined with Epinephrine.]
[L01EN01, erdafitinib, The metabolism of Erdafitinib can be decreased when combined with Epinephrine.]
[H02AB14, cloprednol, The risk or severity of hypokalemia can be increased when Cloprednol is combined with Epinephrine.]
[C09CA06, candesartan, The metabolism of Candesartan can be decreased when combined with Epinephrine.]
[H02AB17, cortivazol, The risk or severity of hypokalemia can be increased when Cortivazol is combined with Epinephrine.]
[L01EM03, alpelisib, The metabolism of Alpelisib can be decreased when combined with Epinephrine.]
[L01EX15, pexidartinib, The metabolism of Pexidartinib can be decreased when combined with Epinephrine.]
[C03BX03, cicletanine, The risk or severity of Cardiac Arrhythmia can be increased when Epinephrine is combined with Cicletanine.]
[L01EX14, entrectinib, The metabolism of Entrectinib can be decreased when combined with Epinephrine.]
[N07XX11, pitolisant, The risk or severity of adverse effects can be increased when Pitolisant is combined with Epinephrine.]
[J04AK08, pretomanid, The metabolism of Pretomanid can be decreased when combined with Epinephrine.]
[J01XX12, lefamulin, The metabolism of Lefamulin can be decreased when combined with Epinephrine.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be decreased when combined with Epinephrine.]
[C03AA09, cyclothiazide, The risk or severity of hypokalemia can be increased when Epinephrine is combined with Cyclothiazide.]
[G04BE04, yohimbine, Yohimbine may decrease the hypertensive activities of Epinephrine.]
[A10AE03, insulin, regular, pork, The therapeutic efficacy of Insulin pork can be decreased when used in combination with Epinephrine.]
[J01DB01, cephalexin, The metabolism of Cephalexin can be decreased when combined with Epinephrine.]
[H02AB13, deflazacort, The risk or severity of hypokalemia can be increased when Deflazacort is combined with Epinephrine.]
[L01FD03, ado-trastuzumab emtansine, The metabolism of Trastuzumab emtansine can be decreased when combined with Epinephrine.]
[L01EL03, zanubrutinib, The metabolism of Zanubrutinib can be decreased when combined with Epinephrine.]
[G03AC09, desogestrel, The metabolism of Desogestrel can be decreased when combined with Epinephrine.]
[B06AX03, voxelotor, The serum concentration of Voxelotor can be increased when it is combined with Epinephrine.]
[R06AB06, dexbrompheniramine, The therapeutic efficacy of Epinephrine can be increased when used in combination with Dexbrompheniramine.]
[R06AB02, dexchlorpheniramine, The therapeutic efficacy of Epinephrine can be increased when used in combination with Dexchlorpheniramine.]
[L01EX18, avapritinib, The metabolism of Avapritinib can be decreased when combined with Epinephrine.]
[L01XX72, tazemetostat, The metabolism of Tazemetostat can be decreased when combined with Epinephrine.]
[J05AE05, amprenavir, The metabolism of Amprenavir can be decreased when combined with Epinephrine.]
[N02CC07, frovatriptan, The risk or severity of hypertension can be increased when Epinephrine is combined with Frovatriptan.]
[G04CB02, dutasteride, Dutasteride may decrease the hypertensive activities of Epinephrine.]
[L01EE04, selumetinib, The metabolism of Selumetinib can be decreased when combined with Epinephrine.]
[N02CC06, eletriptan, The metabolism of Eletriptan can be decreased when combined with Epinephrine.]
[M01AH02, rofecoxib, The metabolism of Rofecoxib can be decreased when combined with Epinephrine.]
[L01XF03, bexarotene, The metabolism of Bexarotene can be decreased when combined with Epinephrine.]
[C01BD07, dronedarone, The metabolism of Dronedarone can be decreased when combined with Epinephrine.]
[R06AA07, diphenylpyraline, The therapeutic efficacy of Epinephrine can be increased when used in combination with Diphenylpyraline.]
[R06AE04, chlorcyclizine, The therapeutic efficacy of Epinephrine can be increased when used in combination with Chlorcyclizine.]
[C02AA06, methoserpidine, Epinephrine may decrease the antihypertensive activities of Methoserpidine.]
[L01EH03, tucatinib, The serum concentration of Epinephrine can be increased when it is combined with Tucatinib.]
[A03AA08, dihexyverine, The risk or severity of Tachycardia can be increased when Epinephrine is combined with Dihexyverine.]
[N04BX04, opicapone, The metabolism of Epinephrine can be decreased when combined with Opicapone.]
[C01CA14, dopexamine, The risk or severity of hypertension can be increased when Epinephrine is combined with Dopexamine.]
[D07XB03, fluprednidene, The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Epinephrine.]
[G04BD09, trospium, The risk or severity of Tachycardia can be increased when Trospium is combined with Epinephrine.]
[M01AC04, droxicam, The risk or severity of hypertension can be increased when Epinephrine is combined with Droxicam.]
[L01EX22, selpercatinib, The risk or severity of hypertension can be increased when Epinephrine is combined with Selpercatinib.]
[M02AA27, dexketoprofen, The risk or severity of hypertension can be increased when Epinephrine is combined with Dexketoprofen.]
[C08CA17, levamlodipine, The serum concentration of Levamlodipine can be increased when it is combined with Epinephrine.]
[R06AX22, ebastine, The metabolism of Ebastine can be decreased when combined with Epinephrine.]
[P01BB01, proguanil, The metabolism of Proguanil can be decreased when combined with Epinephrine.]
[C03AA04, chlorothiazide, The risk or severity of hypokalemia can be increased when Epinephrine is combined with Chlorothiazide.]
[N05AA01, chlorpromazine, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Chlorpromazine.]
[A10BB02, chlorpropamide, The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Epinephrine.]
[N05AF03, chlorprothixene, The risk or severity of Tachycardia can be increased when Epinephrine is combined with Chlorprothixene.]
[C03BA04, chlorthalidone, The risk or severity of Cardiac Arrhythmia can be increased when Epinephrine is combined with Chlorthalidone.]
[N02BA07, ethenzamide, The risk or severity of hypertension can be increased when Epinephrine is combined with Ethenzamide.]
[N02BA03, choline salicylate, The serum concentration of Choline salicylate can be increased when it is combined with Epinephrine.]
[M01AB08, etodolac, The metabolism of Etodolac can be decreased when combined with Epinephrine.]
[M02AA06, etofenamate, The risk or severity of hypertension can be increased when Epinephrine is combined with Etofenamate.]
[A16AX20, lonafarnib, The serum concentration of Lonafarnib can be increased when it is combined with Epinephrine.]
[L01FX21, naxitamab, The risk or severity of hypertension can be increased when Epinephrine is combined with Naxitamab.]
[V03AF12, trilaciclib, The serum concentration of Epinephrine can be increased when it is combined with Trilaciclib.]
[M01AE05, fenbufen, The risk or severity of hypertension can be increased when Epinephrine is combined with Fenbufen.]
[N06BA10, fenethylline, The risk or severity of adverse effects can be increased when Epinephrine is combined with Fenethylline.]
[C01CA19, fenoldopam, Epinephrine may decrease the antihypertensive activities of Fenoldopam.]
[N06BA08, fenozolone, The therapeutic efficacy of Fenozolone can be increased when used in combination with Epinephrine.]
[G04CB01, finasteride, The risk or severity of hypertension can be increased when Epinephrine is combined with Finasteride.]
[R03BA03, flunisolide, The risk or severity of hypokalemia can be increased when Flunisolide is combined with Epinephrine.]
[R03CC15, formoterol, Epinephrine may increase the sympathomimetic activities of Formoterol.]
[A10AF01, insulin, regular, human, The therapeutic efficacy of Insulin human can be decreased when used in combination with Epinephrine.]
[N01AB05, trichloroethylene, Trichloroethylene may increase the arrhythmogenic activities of Epinephrine.]
[H04AA02, dasiglucagon, Epinephrine may decrease the antihypertensive activities of Dasiglucagon.]
[G03GA06, follitropin beta, The risk or severity of adverse effects can be increased when Epinephrine is combined with Follitropin.]
[A02BA01, cimetidine, The serum concentration of Epinephrine can be increased when it is combined with Cimetidine.]
[N07CA02, cinnarizine, The metabolism of Cinnarizine can be decreased when combined with Epinephrine.]
[L01EN03, infigratinib, The metabolism of Infigratinib can be decreased when combined with Epinephrine.]
[L01XA01, cisplatin, The serum concentration of Cisplatin can be increased when it is combined with Epinephrine.]
[C03DA05, finerenone, The serum concentration of Finerenone can be increased when it is combined with Epinephrine.]
[P01CA03, fexinidazole, The serum concentration of Epinephrine can be increased when it is combined with Fexinidazole.]
[R06AA04, clemastine, The therapeutic efficacy of Epinephrine can be increased when used in combination with Clemastine.]
[A10BB12, glimepiride, The therapeutic efficacy of Glimepiride can be decreased when used in combination with Epinephrine.]
[A10BB08, gliquidone, The therapeutic efficacy of Gliquidone can be decreased when used in combination with Epinephrine.]
[R03CC13, clenbuterol, The therapeutic efficacy of Clenbuterol can be increased when used in combination with Epinephrine.]
[D11AH08, abrocitinib, The metabolism of Abrocitinib can be decreased when combined with Epinephrine.]
[L01EJ03, pacritinib, The serum concentration of Epinephrine can be increased when it is combined with Pacritinib.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be decreased when combined with Epinephrine.]
[S01EA04, clonidine, The metabolism of Clonidine can be decreased when combined with Epinephrine.]
[C01EB24, mavacamten, The metabolism of Mavacamten can be decreased when combined with Epinephrine.]
[A10BX16, tirzepatide, The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Epinephrine.]
[C03BA03, clopamide, The risk or severity of Cardiac Arrhythmia can be increased when Epinephrine is combined with Clopamide.]
[A04AA01, ondansetron, The metabolism of Ondansetron can be decreased when combined with Epinephrine.]
[N05AH02, clozapine, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Clozapine.]
[A10BX01, guar gum, The therapeutic efficacy of Guar gum can be decreased when used in combination with Epinephrine.]
[A10BK06, sotagliflozin, The therapeutic efficacy of Sotagliflozin can be decreased when used in combination with Epinephrine.]
[S02DA02, cocaine, The risk or severity of Tachycardia can be increased when Epinephrine is combined with Cocaine.]
[C02KB01, metyrosine, Epinephrine may decrease the antihypertensive activities of Metyrosine.]
[M01AX13, proquazone, The risk or severity of hypertension can be increased when Epinephrine is combined with Proquazone.]
[R05DA04, codeine, The risk or severity of adverse effects can be increased when Codeine is combined with Epinephrine.]
[M04AC01, colchicine, The metabolism of Colchicine can be decreased when combined with Epinephrine.]
[A03AB10, hexocyclium, The risk or severity of Tachycardia can be increased when Epinephrine is combined with Hexocyclium.]
[A03BB06, homatropine methylbromide, The risk or severity of Tachycardia can be increased when Epinephrine is combined with Homatropine methylbromide.]
[L04AA13, leflunomide, The metabolism of Leflunomide can be decreased when combined with Epinephrine.]
[N01AB07, desflurane, Desflurane may increase the arrhythmogenic activities of Epinephrine.]
[C04AX28, ifenprodil, Ifenprodil may decrease the hypertensive activities of Epinephrine.]
[A10BX03, nateglinide, The therapeutic efficacy of Nateglinide can be decreased when used in combination with Epinephrine.]
[N02BA16, imidazole-2-hydroxybenzoate, The risk or severity of hypertension can be increased when Epinephrine is combined with Imidazole salicylate.]
[H01AC03, mecasermin, The therapeutic efficacy of Mecasermin can be decreased when used in combination with Epinephrine.]
[A10AE04, insulin glargine, The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Epinephrine.]
[R03BA08, ciclesonide, The risk or severity of hypokalemia can be increased when Ciclesonide is combined with Epinephrine.]
[B01AC10, indobufen, The risk or severity of hypertension can be increased when Epinephrine is combined with Indobufen.]
[R06AX27, desloratadine, The therapeutic efficacy of Epinephrine can be increased when used in combination with Desloratadine.]
[M01AH03, valdecoxib, The metabolism of Valdecoxib can be decreased when combined with Epinephrine.]
[C01AA06, lanatoside C, The risk or severity of Cardiac Arrhythmia can be increased when Epinephrine is combined with Lanatoside C.]
[A03AX10, isometheptene, The risk or severity of hypertension can be increased when Epinephrine is combined with Isometheptene.]
[N02CC05, almotriptan, The risk or severity of hypertension can be increased when Epinephrine is combined with Almotriptan.]
[M01AH04, parecoxib, The metabolism of Parecoxib can be decreased when combined with Epinephrine.]
[R06AD09, isothipendyl, The therapeutic efficacy of Epinephrine can be increased when used in combination with Isothipendyl.]
[S01AD03, acyclovir, The risk or severity of adverse effects can be increased when Acyclovir is combined with Epinephrine.]
[M01AA06, kebuzone, The risk or severity of hypertension can be increased when Epinephrine is combined with Kebuzone.]
[L01EA01, imatinib, The serum concentration of Epinephrine can be increased when it is combined with Imatinib.]
[C08CA09, lacidipine, Epinephrine may decrease the antihypertensive activities of Lacidipine.]
[N03AX09, lamotrigine, The serum concentration of Epinephrine can be increased when it is combined with Lamotrigine.]
[S01BA03, cortisone, The risk or severity of hypokalemia can be increased when Cortisone is combined with Epinephrine.]
[N07BC04, lofexidine, Epinephrine may decrease the antihypertensive activities of Lofexidine.]
[M01AB09, lonazolac, The risk or severity of hypertension can be increased when Epinephrine is combined with Lonazolac.]
[R06AX13, loratadine, The therapeutic efficacy of Epinephrine can be increased when used in combination with Loratadine.]
[M02AA31, loxoprofen, The risk or severity of hypertension can be increased when Epinephrine is combined with Loxoprofen.]
[C09AA03, lisinopril, Epinephrine may decrease the antihypertensive activities of Lisinopril.]
[C08CA11, manidipine, Epinephrine may decrease the antihypertensive activities of Manidipine.]
[A03AA04, mebeverine, The risk or severity of Tachycardia can be increased when Epinephrine is combined with Mebeverine.]
[R06AX15, mebhydroline, The therapeutic efficacy of Epinephrine can be increased when used in combination with Mebhydrolin.]
[A08AA09, mefenorex, The therapeutic efficacy of Mefenorex can be increased when used in combination with Epinephrine.]
[C07AA14, mepindolol, Mepindolol may decrease the bronchodilatory activities of Epinephrine.]
[H02AB15, meprednisone, The risk or severity of hypokalemia can be increased when Meprednisone is combined with Epinephrine.]
[R06AD07, mequitazine, The therapeutic efficacy of Epinephrine can be increased when used in combination with Mequitazine.]
[C01EB10, adenosine, The risk or severity of Tachycardia can be increased when Adenosine is combined with Epinephrine.]
[R06AD04, methdilazine, The therapeutic efficacy of Epinephrine can be increased when used in combination with Methdilazine.]
[N04AA03, methixene, The risk or severity of Tachycardia can be increased when Metixene is combined with Epinephrine.]
[R03CB02, methoxyphenamine, The therapeutic efficacy of Methoxyphenamine can be increased when used in combination with Epinephrine.]
[R06AE03, cyclizine, The therapeutic efficacy of Epinephrine can be increased when used in combination with Cyclizine.]
[C03DA04, eplerenone, The risk or severity of Cardiac Arrhythmia can be increased when Epinephrine is combined with Eplerenone.]
[C03AA07, cyclopenthiazide, The risk or severity of hypokalemia can be increased when Epinephrine is combined with Cyclopenthiazide.]
[A10BF02, miglitol, The therapeutic efficacy of Miglitol can be decreased when used in combination with Epinephrine.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be decreased when combined with Epinephrine.]
[N06AX07, minaprine, Minaprine may increase the hypertensive activities of Epinephrine.]
[S01XA18, cyclosporine, The metabolism of Cyclosporine can be decreased when combined with Epinephrine.]
[N06AG02, moclobemide, Moclobemide may increase the hypertensive activities of Epinephrine.]
[R06AX02, cyproheptadine, The therapeutic efficacy of Epinephrine can be increased when used in combination with Cyproheptadine.]
[C09AA13, moexipril, Epinephrine may decrease the antihypertensive activities of Moexipril.]
[C10AA07, rosuvastatin, The metabolism of Rosuvastatin can be decreased when combined with Epinephrine.]
[M02AA02, mofebutazone, The risk or severity of hypertension can be increased when Epinephrine is combined with Mofebutazone.]
[M01AX22, morniflumate, The risk or severity of hypertension can be increased when Epinephrine is combined with Morniflumate.]
[C03XA02, conivaptan, The metabolism of Conivaptan can be decreased when combined with Epinephrine.]
[C02AC05, moxonidine, Epinephrine may decrease the antihypertensive activities of Moxonidine.]
[G04BE09, vardenafil, The metabolism of Vardenafil can be decreased when combined with Epinephrine.]
[M01AH05, etoricoxib, The metabolism of Etoricoxib can be decreased when combined with Epinephrine.]
[J04BA02, dapsone, The metabolism of Dapsone can be decreased when combined with Epinephrine.]
[C02CC04, debrisoquin, Epinephrine may decrease the antihypertensive activities of Debrisoquine.]
[A04AD11, nabilone, The metabolism of Nabilone can be decreased when combined with Epinephrine.]
[M01AX01, nabumetone, The metabolism of Nabumetone can be decreased when combined with Epinephrine.]
[C07AB12, nebivolol, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Nebivolol.]
[N06AX06, nefazodone, Nefazodone may increase the tachycardic activities of Epinephrine.]
[C01DX16, nicorandil, Epinephrine may decrease the antihypertensive activities of Nicorandil.]
[C01CA23, theodrenaline, The therapeutic efficacy of Epinephrine can be increased when used in combination with Theodrenaline.]
[C01CA05, norfenefrine, The risk or severity of hypertension can be increased when Epinephrine is combined with Norfenefrine.]
[G04BD08, solifenacin, The risk or severity of hypertension can be increased when Epinephrine is combined with Solifenacin.]
[A07EC03, olsalazine, The risk or severity of hypertension can be increased when Epinephrine is combined with Olsalazine.]
[N06AA01, desipramine, Desipramine may increase the vasopressor activities of Epinephrine.]
[C01AA07, deslanoside, The risk or severity of Cardiac Arrhythmia can be increased when Epinephrine is combined with Deslanoside.]
[H01BA02, desmopressin, The risk or severity of hypertension can be increased when Desmopressin is combined with Epinephrine.]
[D07XC02, desoximetasone, The risk or severity of hypokalemia can be increased when Desoximetasone is combined with Epinephrine.]
[H02AA03, desoxycorticosterone, The risk or severity of hypokalemia can be increased when Desoxycortone is combined with Epinephrine.]
[C09XA02, aliskiren, Epinephrine may decrease the antihypertensive activities of Aliskiren.]
[L01XA03, oxaliplatin, The serum concentration of Oxaliplatin can be increased when it is combined with Epinephrine.]
[M01AE12, oxaprozin, The risk or severity of hypertension can be increased when Epinephrine is combined with Oxaprozin.]
[S03BA01, dexamethasone, The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Epinephrine.]
[N04AA08, dexetimide, The risk or severity of Tachycardia can be increased when Epinephrine is combined with Dexetimide.]
[G04BD04, oxybutynin, The risk or severity of Tachycardia can be increased when Epinephrine is combined with Oxybutynin.]
[A03AA01, oxyphencyclimine, The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Epinephrine.]
[N06BA02, dextroamphetamine, The therapeutic efficacy of Amphetamine can be increased when used in combination with Epinephrine.]
[R05DA09, dextromethorphan, The metabolism of Dextromethorphan can be decreased when combined with Epinephrine.]
[N03AC01, paramethadione, The metabolism of Paramethadione can be decreased when combined with Epinephrine.]
[H05AA02, teriparatide, The risk or severity of adverse effects can be increased when Epinephrine is combined with Teriparatide.]
[N06AB05, paroxetine, The risk or severity of Tachycardia can be increased when Epinephrine is combined with Paroxetine.]
[B01AC04, clopidogrel, The serum concentration of Epinephrine can be increased when it is combined with Clopidogrel.]
[C04AD01, pentifylline, The risk or severity of adverse effects can be increased when Epinephrine is combined with Pentifylline.]
[N05BA01, diazepam, The metabolism of Diazepam can be decreased when combined with Epinephrine.]
[V03AH01, diazoxide, Epinephrine may decrease the antihypertensive activities of Diazoxide.]
[R06AX04, phenindamine, The therapeutic efficacy of Epinephrine can be increased when used in combination with Phenindamine.]
[N06AA08, dibenzepin, Dibenzepin may increase the vasopressor activities of Epinephrine.]
[S01EC02, dichlorphenamide, The risk or severity of Cardiac Arrhythmia can be increased when Epinephrine is combined with Diclofenamide.]
[S01BC03, diclofenac, The metabolism of Diclofenac can be decreased when combined with Epinephrine.]
[A03AA07, dicyclomine, The risk or severity of Tachycardia can be increased when Epinephrine is combined with Dicyclomine.]
[R06AX23, pimethixene, The therapeutic efficacy of Epinephrine can be increased when used in combination with Pimethixene.]
[C02DG01, pinacidil, Epinephrine may decrease the antihypertensive activities of Pinacidil.]
[A10BG03, pioglitazone, The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Epinephrine.]
[A03AB14, pipenzolate, The risk or severity of Tachycardia can be increased when Epinephrine is combined with Pipenzolate.]
[L01DC04, ixabepilone, The metabolism of Ixabepilone can be decreased when combined with Epinephrine.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be decreased when combined with Epinephrine.]
[R03CC07, pirbuterol, The risk or severity of adverse effects can be increased when Epinephrine is combined with Pirbuterol.]
[C03CA03, piretanide, The risk or severity of hypokalemia can be increased when Epinephrine is combined with Piretanide.]
[A08AA03, diethylpropion, The therapeutic efficacy of Diethylpropion can be increased when used in combination with Epinephrine.]
[C08CA03, isradipine, Epinephrine may decrease the antihypertensive activities of Isradipine.]
[D07XC04, diflucortolone, The risk or severity of hypokalemia can be increased when Difluocortolone is combined with Epinephrine.]
[A03AB11, poldine, The risk or severity of Tachycardia can be increased when Epinephrine is combined with Poldine.]
[N02BA11, diflunisal, The risk or severity of hypertension can be increased when Epinephrine is combined with Diflunisal.]
[C01AA04, digitoxin, The metabolism of Digitoxin can be decreased when combined with Epinephrine.]
[C01AA05, digoxin, The risk or severity of Cardiac Arrhythmia can be increased when Epinephrine is combined with Digoxin.]
[C02DB01, dihydralazine, Epinephrine may decrease the antihypertensive activities of Dihydralazine.]
[C04AE04, dihydroergocristine, Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Epinephrine.]
[N02CA01, dihydroergotamine, The metabolism of Dihydroergotamine can be decreased when combined with Epinephrine.]
[N02AA03, hydromorphone, The metabolism of Hydromorphone can be decreased when combined with Epinephrine.]
[J05AE08, atazanavir, The metabolism of Atazanavir can be decreased when combined with Epinephrine.]
[B01AC21, treprostinil, The metabolism of Treprostinil can be decreased when combined with Epinephrine.]
[H03BC01, potassium perchlorate, The risk or severity of adverse effects can be increased when Epinephrine is combined with Potassium perchlorate.]
[C08DB01, diltiazem, The metabolism of Diltiazem can be decreased when combined with Epinephrine.]
[R06AA11, dimenhydrinate, The therapeutic efficacy of Epinephrine can be increased when used in combination with Dimenhydrinate.]
[R06AB03, dimethindene, The therapeutic efficacy of Epinephrine can be increased when used in combination with Dimetindene.]
[R03CC08, procaterol, The therapeutic efficacy of Procaterol can be increased when used in combination with Epinephrine.]
[N06BC02, propentofylline, The risk or severity of adverse effects can be increased when Epinephrine is combined with Propentofylline.]
[N02BB04, propyphenazone, The risk or severity of hypertension can be increased when Epinephrine is combined with Propyphenazone.]
[M01AB14, proglumetacin, The risk or severity of hypertension can be increased when Epinephrine is combined with Proglumetacin.]
[G02AD02, dinoprostone, The serum concentration of Epinephrine can be increased when it is combined with Dinoprostone.]
[R03DA03, proxyphylline, The risk or severity of adverse effects can be increased when Epinephrine is combined with Proxyphylline.]
[R06AA02, diphenhydramine, The serum concentration of Epinephrine can be increased when it is combined with Diphenhydramine.]
[N05CD10, quazepam, The metabolism of Quazepam can be decreased when combined with Epinephrine.]
[C09AA06, quinapril, Epinephrine may decrease the antihypertensive activities of Quinapril.]
[N06BA11, dexmethylphenidate, The risk or severity of hypertension can be increased when Epinephrine is combined with Dexmethylphenidate.]
[N06AA23, quinupramine, Quinupramine may increase the vasopressor activities of Epinephrine.]
[A03FA02, cisapride, The metabolism of Cisapride can be decreased when combined with Epinephrine.]
[C09AA05, ramipril, Epinephrine may decrease the antihypertensive activities of Ramipril.]
[S01XA23, sirolimus, The metabolism of Sirolimus can be decreased when combined with Epinephrine.]
[R03CC14, reproterol, The risk or severity of hypertension can be increased when Epinephrine is combined with Reproterol.]
[C01BA03, disopyramide, The therapeutic efficacy of Disopyramide can be decreased when used in combination with Epinephrine.]
[N05AX08, risperidone, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Risperidone.]
[R06AE09, levocetirizine, The therapeutic efficacy of Epinephrine can be increased when used in combination with Levocetirizine.]
[L01EX01, sunitinib, The metabolism of Sunitinib can be decreased when combined with Epinephrine.]
[C03XA01, tolvaptan, The metabolism of Tolvaptan can be decreased when combined with Epinephrine.]
[L01XG01, bortezomib, The metabolism of Bortezomib can be decreased when combined with Epinephrine.]
[G04BE08, tadalafil, Epinephrine may decrease the antihypertensive activities of Tadalafil.]
[S01BC05, ketorolac, The metabolism of Ketorolac can be decreased when combined with Epinephrine.]
[C02KX02, ambrisentan, Epinephrine may decrease the antihypertensive activities of Ambrisentan.]
[C01EB18, ranolazine, The serum concentration of Epinephrine can be increased when it is combined with Ranolazine.]
[N02BA06, salsalate, The risk or severity of hypertension can be increased when Epinephrine is combined with Salsalate.]
[R03AC12, salmeterol, The risk or severity of adverse effects can be increased when Epinephrine is combined with Salmeterol.]
[H05BA01, salmon calcitonin, The risk or severity of adverse effects can be increased when Epinephrine is combined with Salmon calcitonin.]
[C01CA07, dobutamine, The therapeutic efficacy of Dobutamine can be increased when used in combination with Epinephrine.]
[C01CA04, dopamine, The therapeutic efficacy of Dopamine can be increased when used in combination with Epinephrine.]
[N06AA16, dothiepin, Dosulepin may increase the vasopressor activities of Epinephrine.]
[R07AB01, doxapram, The risk or severity of hypertension can be increased when Doxapram is combined with Epinephrine.]
[N06AA12, doxepin, Doxepin may increase the vasopressor activities of Epinephrine.]
[L01DB01, doxorubicin, The metabolism of Doxorubicin can be decreased when combined with Epinephrine.]
[R06AA09, doxylamine, The therapeutic efficacy of Epinephrine can be increased when used in combination with Doxylamine.]
[N06AB06, sertraline, The metabolism of Sertraline can be decreased when combined with Epinephrine.]
[N01AB08, sevoflurane, Sevoflurane may increase the arrhythmogenic activities of Epinephrine.]
[N05AD08, droperidol, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Droperidol.]
[A08AA10, sibutramine, Sibutramine may increase the tachycardic activities of Epinephrine.]
[C09AA11, spirapril, Epinephrine may decrease the antihypertensive activities of Spirapril.]
[R03DA01, dyphylline, The risk or severity of adverse effects can be increased when Epinephrine is combined with Dyphylline.]
[N02CC01, sumatriptan, The risk or severity of hypertension can be increased when Epinephrine is combined with Sumatriptan.]
[C07AB13, talinolol, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Talinolol.]
[H01AA01, corticotropin, The risk or severity of hypokalemia can be increased when Corticotropin is combined with Epinephrine.]
[M01AC02, tenoxicam, The metabolism of Tenoxicam can be decreased when combined with Epinephrine.]
[G04CA03, terazosin, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Terazosin.]
[D01BA02, terbinafine, The metabolism of Terbinafine can be decreased when combined with Epinephrine.]
[C07AA16, tertatolol, Tertatolol may decrease the bronchodilatory activities of Epinephrine.]
[S01GA02, tetrahydrozoline, The therapeutic efficacy of Tetryzoline can be increased when used in combination with Epinephrine.]
[G04BD01, emepronium, The risk or severity of Tachycardia can be increased when Epinephrine is combined with Emepronium.]
[N06AX14, tianeptine, The metabolism of Tianeptine can be decreased when combined with Epinephrine.]
[C09AA02, enalapril, Epinephrine may decrease the antihypertensive activities of Enalapril.]
[M01AG02, tolfenamic acid, The risk or severity of hypertension can be increased when Epinephrine is combined with Tolfenamic acid.]
[N06AG03, toloxatone, Toloxatone may increase the hypertensive activities of Epinephrine.]
[N06BA09, atomoxetine, Atomoxetine may increase the tachycardic activities of Epinephrine.]
[C03CA04, torsemide, The risk or severity of hypokalemia can be increased when Epinephrine is combined with Torasemide.]
[R01AA09, tramazoline, The therapeutic efficacy of Tramazoline can be increased when used in combination with Epinephrine.]
[C09AA10, trandolapril, Epinephrine may decrease the antihypertensive activities of Trandolapril.]
[A03AB08, tridihexethyl, The risk or severity of Tachycardia can be increased when Tridihexethyl is combined with Epinephrine.]
[H02CA01, trilostane, The risk or severity of hypokalemia can be increased when Trilostane is combined with Epinephrine.]
[R06AA10, trimethobenzamide, The therapeutic efficacy of Epinephrine can be increased when used in combination with Trimethobenzamide.]
[G03GA05, follitropin alfa, The risk or severity of adverse effects can be increased when Epinephrine is combined with Follitropin.]
[R06AX21, tritoqualine, The therapeutic efficacy of Epinephrine can be increased when used in combination with Tritoqualine.]
[N04AA12, tropatepine, The risk or severity of Tachycardia can be increased when Epinephrine is combined with Tropatepine.]
[R03CC11, tulobuterol, The risk or severity of hypertension can be increased when Epinephrine is combined with Tulobuterol.]
[N01AB04, enflurane, Enflurane may increase the arrhythmogenic activities of Epinephrine.]
[C02CA06, urapidil, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Urapidil.]
[L01CA04, vinorelbine, The metabolism of Vinorelbine can be decreased when combined with Epinephrine.]
[N06AX16, venlafaxine, Venlafaxine may increase the tachycardic activities of Epinephrine.]
[C01CX07, xamoterol, The risk or severity of hypertension can be increased when Epinephrine is combined with Xamoterol.]
[S01GA03, xylometazoline, The risk or severity of hypertension can be increased when Epinephrine is combined with Xylometazoline.]
[S02BA08, fluocinolone acetonide, The risk or severity of hypokalemia can be increased when Fluocinolone acetonide is combined with Epinephrine.]
[M01AG01, mefenamic acid, The metabolism of Mefenamic acid can be decreased when combined with Epinephrine.]
[C09AA15, zofenopril, Epinephrine may decrease the antihypertensive activities of Zofenopril.]
[N05CF02, zolpidem, The metabolism of Zolpidem can be decreased when combined with Epinephrine.]
[M01AB04, zomepirac, The risk or severity of hypertension can be increased when Epinephrine is combined with Zomepirac.]
[N03AX15, zonisamide, The risk or severity of Cardiac Arrhythmia can be increased when Epinephrine is combined with Zonisamide.]
[A10AB06, insulin glulisine, human, The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Epinephrine.]
[N05CF01, zopiclone, The metabolism of Zopiclone can be decreased when combined with Epinephrine.]
[C02AC02, guanfacine, The risk or severity of adverse effects can be increased when Guanfacine is combined with Epinephrine.]
[G02AB03, ergonovine, Ergometrine may increase the hypertensive and vasoconstricting activities of Epinephrine.]
[C04AE01, ergoloid mesylates, USP, Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Epinephrine.]
[N02CA02, ergotamine, The metabolism of Ergotamine can be decreased when combined with Epinephrine.]
[G03CA03, estradiol, The serum concentration of Epinephrine can be increased when it is combined with Estradiol.]
[R03BA09, fluticasone furoate, The risk or severity of hypokalemia can be increased when Fluticasone furoate is combined with Epinephrine.]
[R03BA05, fluticasone, The risk or severity of hypokalemia can be increased when Fluticasone is combined with Epinephrine.]
[C10AA04, fluvastatin, The metabolism of Fluvastatin can be decreased when combined with Epinephrine.]
[C01CA15, gepefrine, The therapeutic efficacy of Gepefrine can be increased when used in combination with Epinephrine.]
[L02AA03, ethinyl estradiol, The metabolism of Ethinylestradiol can be decreased when combined with Epinephrine.]
[N04AA05, profenamine, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Profenamine.]
[M01AC06, meloxicam, The metabolism of Meloxicam can be decreased when combined with Epinephrine.]
[C01CA01, etilefrine, The therapeutic efficacy of Etilefrine can be increased when used in combination with Epinephrine.]
[N01AX07, etomidate, The risk or severity of hypertension can be increased when Etomidate is combined with Epinephrine.]
[L01CB01, etoposide, The metabolism of Etoposide can be decreased when combined with Epinephrine.]
[L04AD02, tacrolimus, The serum concentration of Tacrolimus can be increased when it is combined with Epinephrine.]
[R06AX11, astemizole, The metabolism of Astemizole can be decreased when combined with Epinephrine.]
[R06AX12, terfenadine, The metabolism of Terfenadine can be decreased when combined with Epinephrine.]
[N06AX12, bupropion, The excretion of Epinephrine can be decreased when combined with Bupropion.]
[A02BA03, famotidine, The serum concentration of Epinephrine can be increased when it is combined with Famotidine.]
[P02CA03, albendazole, The metabolism of Albendazole can be decreased when combined with Epinephrine.]
[C08CA02, felodipine, Epinephrine may decrease the antihypertensive activities of Felodipine.]
[M01AE04, fenoprofen, The risk or severity of hypertension can be increased when Fenoprofen is combined with Epinephrine.]
[R03CC04, fenoterol, The therapeutic efficacy of Fenoterol can be increased when used in combination with Epinephrine.]
[N02AB03, fentanyl, The metabolism of Fentanyl can be decreased when combined with Epinephrine.]
[R03CC02, albuterol, The risk or severity of adverse effects can be increased when Epinephrine is combined with Salbutamol.]
[L01BB06, clofarabine, The serum concentration of Clofarabine can be increased when it is combined with Epinephrine.]
[G04BD02, flavoxate, The risk or severity of Tachycardia can be increased when Epinephrine is combined with Flavoxate.]
[N02BG04, floctafenine, The risk or severity of hypertension can be increased when Epinephrine is combined with Floctafenine.]
[H02AA02, fludrocortisone, The risk or severity of hypokalemia can be increased when Fludrocortisone is combined with Epinephrine.]
[D07XB01, flumethasone, The risk or severity of hypokalemia can be increased when Flumethasone is combined with Epinephrine.]
[N07CA03, flunarizine, The metabolism of Flunarizine can be decreased when combined with Epinephrine.]
[N05CD03, flunitrazepam, The metabolism of Flunitrazepam can be decreased when combined with Epinephrine.]
[D07AC08, fluocinonide, The risk or severity of hypokalemia can be increased when Fluocinonide is combined with Epinephrine.]
[N06AA14, melitracen, Melitracen may increase the vasopressor activities of Epinephrine.]
[H02AB03, fluocortolone, The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Epinephrine.]
[S01CB05, fluorometholone, The risk or severity of hypokalemia can be increased when Fluorometholone is combined with Epinephrine.]
[N06AB03, fluoxetine, The metabolism of Fluoxetine can be decreased when combined with Epinephrine.]
[N05AF01, flupenthixol, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Flupentixol.]
[N05CD01, flurazepam, The serum concentration of Epinephrine can be increased when it is combined with Flurazepam.]
[S01BC04, flurbiprofen, The metabolism of Flurbiprofen can be decreased when combined with Epinephrine.]
[N06BX17, adrafinil, The risk or severity of hypertension can be increased when Epinephrine is combined with Adrafinil.]
[G01AX06, furazolidone, Furazolidone may increase the hypertensive activities of Epinephrine.]
[C03CA01, furosemide, The risk or severity of hypokalemia can be increased when Epinephrine is combined with Furosemide.]
[N05CF04, eszopiclone, The metabolism of Eszopiclone can be decreased when combined with Epinephrine.]
[S01AD09, ganciclovir, The risk or severity of adverse effects can be increased when Ganciclovir is combined with Epinephrine.]
[L01EA02, dasatinib, The metabolism of Dasatinib can be decreased when combined with Epinephrine.]
[N04BC06, cabergoline, The metabolism of Cabergoline can be decreased when combined with Epinephrine.]
[C01CA21, cafedrine, The risk or severity of adverse effects can be increased when Epinephrine is combined with Cafedrine.]
[A10BJ02, liraglutide, The therapeutic efficacy of Liraglutide can be decreased when used in combination with Epinephrine.]
[J05AG04, etravirine, The metabolism of Etravirine can be decreased when combined with Epinephrine.]
[N01AH02, alfentanil, The risk or severity of hypertension can be increased when Epinephrine is combined with Alfentanil.]
[A10BB01, glyburide, The therapeutic efficacy of Glyburide can be decreased when used in combination with Epinephrine.]
[A10BB09, gliclazide, The therapeutic efficacy of Gliclazide can be decreased when used in combination with Epinephrine.]
[A10BB07, glipizide, The therapeutic efficacy of Glipizide can be decreased when used in combination with Epinephrine.]
[N05CM18, dexmedetomidine, The risk or severity of hypertension can be increased when Dexmedetomidine is combined with Epinephrine.]
[C05AE01, nitroglycerin, Epinephrine may decrease the antihypertensive activities of Nitroglycerin.]
[C01BD04, dofetilide, The metabolism of Dofetilide can be decreased when combined with Epinephrine.]
[C02CA04, doxazosin, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Doxazosin.]
[H01AB01, thyrotropin alfa, The risk or severity of adverse effects can be increased when Epinephrine is combined with Thyrotropin alfa.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be decreased when combined with Epinephrine.]
[C07AB09, esmolol, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Esmolol.]
[B01AA12, fluindione, The metabolism of Fluindione can be decreased when combined with Epinephrine.]
[C09AA09, fosinopril, Epinephrine may decrease the antihypertensive activities of Fosinopril.]
[S01EX01, guanethidine, Epinephrine may decrease the antihypertensive activities of Guanethidine.]
[N05AD01, haloperidol, The serum concentration of Haloperidol can be increased when it is combined with Epinephrine.]
[N01AB01, halothane, Halothane may increase the arrhythmogenic activities of Epinephrine.]
[N05AH04, quetiapine, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Quetiapine.]
[A10AD05, insulin aspart, human, The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Epinephrine.]
[L01CE02, irinotecan, The metabolism of Irinotecan can be decreased when combined with Epinephrine.]
[C09CA01, losartan, The metabolism of Losartan can be decreased when combined with Epinephrine.]
[G03DC01, allylestrenol, The metabolism of Allylestrenol can be decreased when combined with Epinephrine.]
[A07EC02, mesalamine, The risk or severity of hypertension can be increased when Mesalazine is combined with Epinephrine.]
[N05CA16, hexobarbital, The metabolism of Hexobarbital can be decreased when combined with Epinephrine.]
[R03CC05, hexoprenaline, The risk or severity of adverse effects can be increased when Epinephrine is combined with Hexoprenaline.]
[J05AG01, nevirapine, The metabolism of Nevirapine can be decreased when combined with Epinephrine.]
[C08CA10, nilvadipine, Epinephrine may decrease the antihypertensive activities of Nilvadipine.]
[M02AA26, nimesulide, The risk or severity of hypertension can be increased when Epinephrine is combined with Nimesulide.]
[R06AE06, oxatomide, The therapeutic efficacy of Epinephrine can be increased when used in combination with Oxatomide.]
[C09AA04, perindopril, Epinephrine may decrease the antihypertensive activities of Perindopril.]
[C02DB02, hydralazine, Epinephrine may decrease the antihypertensive activities of Hydralazine.]
[C03AA03, hydrochlorothiazide, The risk or severity of hypokalemia can be increased when Epinephrine is combined with Hydrochlorothiazide.]
[S02BA01, hydrocortisone, The risk or severity of hypokalemia can be increased when Hydrocortisone is combined with Epinephrine.]
[C03AA02, hydroflumethiazide, The risk or severity of hypokalemia can be increased when Epinephrine is combined with Hydroflumethiazide.]
[A12BA02, potassium citrate, The risk or severity of Cardiac Arrhythmia can be increased when Epinephrine is combined with Potassium citrate.]
[G04BD06, propiverine, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Propiverine.]
[C02AC06, rilmenidine, Epinephrine may decrease the antihypertensive activities of Rilmenidine.]
[R02AX02, ibuprofen, The metabolism of Ibuprofen can be decreased when combined with Epinephrine.]
[L01DB06, idarubicin, The metabolism of Idarubicin can be decreased when combined with Epinephrine.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be decreased when combined with Epinephrine.]
[N01AH03, sufentanil, The risk or severity of hypertension can be increased when Epinephrine is combined with Sufentanil.]
[N06AA02, imipramine, Imipramine may increase the vasopressor activities of Epinephrine.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be decreased when combined with Epinephrine.]
[R01AD07, tixocortol, The risk or severity of hypokalemia can be increased when Tixocortol is combined with Epinephrine.]
[M03BX02, tizanidine, The risk or severity of adverse effects can be increased when Tizanidine is combined with Epinephrine.]
[C03BA11, indapamide, The risk or severity of Cardiac Arrhythmia can be increased when Epinephrine is combined with Indapamide.]
[S01BC01, indomethacin, The metabolism of Indomethacin can be decreased when combined with Epinephrine.]
[C02CA02, indoramin, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Indoramin.]
[N06AX17, milnacipran, Milnacipran may increase the tachycardic activities of Epinephrine.]
[A03AA30, piperidolate, The risk or severity of Tachycardia can be increased when Epinephrine is combined with Piperidolate.]
[S01XA28, varenicline, The excretion of Varenicline can be decreased when combined with Epinephrine.]
[A10BH01, sitagliptin, The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Epinephrine.]
[N05BA12, alprazolam, The metabolism of Alprazolam can be decreased when combined with Epinephrine.]
[N05CH02, ramelteon, The metabolism of Ramelteon can be decreased when combined with Epinephrine.]
[R06AE01, buclizine, The therapeutic efficacy of Epinephrine can be increased when used in combination with Buclizine.]
[G02CX01, atosiban, The risk or severity of adverse effects can be increased when Epinephrine is combined with Atosiban.]
[A10BH02, vildagliptin, The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Epinephrine.]
[L01XX35, anagrelide, The risk or severity of Tachycardia can be increased when Anagrelide is combined with Epinephrine.]
[C07AA01, alprenolol, Alprenolol may decrease the bronchodilatory activities of Epinephrine.]
[C03BA02, quinethazone, The risk or severity of Cardiac Arrhythmia can be increased when Epinephrine is combined with Quinethazone.]
[N06AA13, iprindole, Iprindole may increase the vasopressor activities of Epinephrine.]
[N06AF05, iproniazid, Iproniazid may increase the hypertensive activities of Epinephrine.]
[N06AF01, isocarboxazid, Isocarboxazid may increase the hypertensive activities of Epinephrine.]
[R03CC06, isoetharine, The risk or severity of adverse effects can be increased when Isoetharine is combined with Epinephrine.]
[C09AA16, imidapril, Epinephrine may decrease the antihypertensive activities of Imidapril.]
[N01AB06, isoflurane, Isoflurane may increase the arrhythmogenic activities of Epinephrine.]
[N04BX02, entacapone, The metabolism of Epinephrine can be decreased when combined with Entacapone.]
[R03CB01, isoproterenol, The therapeutic efficacy of Isoprenaline can be increased when used in combination with Epinephrine.]
[A10BJ01, exenatide, The therapeutic efficacy of Exenatide can be decreased when used in combination with Epinephrine.]
[C04AA01, isoxsuprine, The therapeutic efficacy of Isoxsuprine can be increased when used in combination with Epinephrine.]
[N01AX03, ketamine, The metabolism of Ketamine can be decreased when combined with Epinephrine.]
[C02KD01, ketanserin, Epinephrine may decrease the antihypertensive activities of Ketanserin.]
[B01AC22, prasugrel, The metabolism of Prasugrel can be decreased when combined with Epinephrine.]
[N05AH03, olanzapine, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Olanzapine.]
[M02AA10, ketoprofen, The risk or severity of hypertension can be increased when Epinephrine is combined with Ketoprofen.]
[R06AX25, mizolastine, The therapeutic efficacy of Epinephrine can be increased when used in combination with Mizolastine.]
[S01GX08, ketotifen, The therapeutic efficacy of Epinephrine can be increased when used in combination with Ketotifen.]
[C01CA22, arbutamine, The risk or severity of adverse effects can be increased when Epinephrine is combined with Arbutamine.]
[N04BC09, rotigotine, The risk or severity of hypertension can be increased when Epinephrine is combined with Rotigotine.]
[C07AG01, labetalol, The therapeutic efficacy of Labetalol can be increased when used in combination with Epinephrine.]
[N04BB01, amantadine, The serum concentration of Amantadine can be increased when it is combined with Epinephrine.]
[C02AA05, deserpidine, Epinephrine may decrease the antihypertensive activities of Deserpidine.]
[N03AX18, lacosamide, The metabolism of Lacosamide can be decreased when combined with Epinephrine.]
[C03CC01, ethacrynic acid, The risk or severity of hypokalemia can be increased when Epinephrine is combined with Etacrynic acid.]
[D06AX13, retapamulin, The metabolism of Retapamulin can be decreased when combined with Epinephrine.]
[C03DB01, amiloride, The serum concentration of Epinephrine can be increased when it is combined with Amiloride.]
[N02CA07, lisuride, Lisuride may increase the hypertensive and vasoconstricting activities of Epinephrine.]
[N06AA07, lofepramine, Lofepramine may increase the vasopressor activities of Epinephrine.]
[C10AA02, lovastatin, The metabolism of Lovastatin can be decreased when combined with Epinephrine.]
[G03DC03, lynestrenol, The metabolism of Lynestrenol can be decreased when combined with Epinephrine.]
[L01EG01, temsirolimus, The metabolism of Temsirolimus can be decreased when combined with Epinephrine.]
[L01EA03, nilotinib, The metabolism of Nilotinib can be decreased when combined with Epinephrine.]
[V04CX04, mannitol, The risk or severity of Cardiac Arrhythmia can be increased when Epinephrine is combined with Mannitol.]
[N06AA21, maprotiline, The risk or severity of Tachycardia can be increased when Epinephrine is combined with Maprotiline.]
[A08AA05, mazindol, The risk or severity of adverse effects can be increased when Mazindol is combined with Epinephrine.]
[C02BB01, mecamylamine, Epinephrine may decrease the antihypertensive activities of Mecamylamine.]
[R06AE05, meclizine, The therapeutic efficacy of Epinephrine can be increased when used in combination with Meclizine.]
[M02AA18, meclofenamic acid, The risk or severity of hypertension can be increased when Epinephrine is combined with Meclofenamic acid.]
[C01AA08, medigoxin, The risk or severity of Cardiac Arrhythmia can be increased when Epinephrine is combined with Metildigoxin.]
[C03BA05, mefruside, The risk or severity of Cardiac Arrhythmia can be increased when Epinephrine is combined with Mefruside.]
[N06DX01, memantine, The serum concentration of Memantine can be increased when it is combined with Epinephrine.]
[N02AB02, meperidine, The metabolism of Meperidine can be decreased when combined with Epinephrine.]
[C01CA11, mephentermine, The therapeutic efficacy of Mephentermine can be increased when used in combination with Epinephrine.]
[N03AB04, mephenytoin, The metabolism of Mephenytoin can be decreased when combined with Epinephrine.]
[C03BC01, mersalyl, The risk or severity of Cardiac Arrhythmia can be increased when Epinephrine is combined with Mersalyl.]
[N05AX13, paliperidone, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Paliperidone.]
[C01CA09, metaraminol, The therapeutic efficacy of Metaraminol can be increased when used in combination with Epinephrine.]
[A10BA02, metformin, The therapeutic efficacy of Metformin can be decreased when used in combination with Epinephrine.]
[N07BC02, methadone, The metabolism of Methadone can be decreased when combined with Epinephrine.]
[N06BA03, methamphetamine, The therapeutic efficacy of Metamfetamine can be increased when used in combination with Epinephrine.]
[A03AB07, methantheline, The risk or severity of Tachycardia can be increased when Epinephrine is combined with Methantheline.]
[R06AC05, methapyrilene, The therapeutic efficacy of Epinephrine can be increased when used in combination with Methapyrilene.]
[J05AF05, lamivudine, The serum concentration of Lamivudine can be increased when it is combined with Epinephrine.]
[S01EC05, methazolamide, The risk or severity of Cardiac Arrhythmia can be increased when Epinephrine is combined with Methazolamide.]
[G02CB05, metergoline, Metergoline may increase the hypertensive and vasoconstricting activities of Epinephrine.]
[H03BB02, methimazole, The risk or severity of adverse effects can be increased when Epinephrine is combined with Methimazole.]
[L04AX03, methotrexate, The metabolism of Methotrexate can be decreased when combined with Epinephrine.]
[N05AA02, methotrimeprazine, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Methotrimeprazine.]
[C01CA10, methoxamine, The therapeutic efficacy of Methoxamine can be increased when used in combination with Epinephrine.]
[N02BG09, methoxyflurane, Methoxyflurane may increase the arrhythmogenic activities of Epinephrine.]
[C03AA08, methyclothiazide, The risk or severity of hypokalemia can be increased when Epinephrine is combined with Methyclothiazide.]
[C02AB01, methyldopa, Epinephrine may decrease the antihypertensive activities of Methyldopa.]
[V04CG05, methylene blue, Methylene blue may increase the hypertensive activities of Epinephrine.]
[G02AB01, methylergonovine, Methylergometrine may increase the hypertensive and vasoconstricting activities of Epinephrine.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be decreased when combined with Epinephrine.]
[N06BA04, methylphenidate, The risk or severity of hypertension can be increased when Methylphenidate is combined with Epinephrine.]
[H02AB04, methylprednisolone, The risk or severity of hypokalemia can be increased when Methylprednisolone is combined with Epinephrine.]
[D07AC14, methylprednisolone aceponate, The risk or severity of hypokalemia can be increased when Methylprednisolone aceponate is combined with Epinephrine.]
[N02CA04, methysergide, Methysergide may increase the hypertensive and vasoconstricting activities of Epinephrine.]
[C03BA08, metolazone, The risk or severity of Cardiac Arrhythmia can be increased when Epinephrine is combined with Metolazone.]
[C07AB02, metoprolol, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Metoprolol.]
[N06AX03, mianserin, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Mianserin.]
[N02BB03, aminopyrine, The metabolism of Aminophenazone can be decreased when combined with Epinephrine.]
[N05CD08, midazolam, The serum concentration of Midazolam can be increased when it is combined with Epinephrine.]
[C01CA17, midodrine, The therapeutic efficacy of Midodrine can be increased when used in combination with Epinephrine.]
[G03XB01, mifepristone, The therapeutic efficacy of Mifepristone can be decreased when used in combination with Epinephrine.]
[C09CA03, valsartan, The metabolism of Valsartan can be decreased when combined with Epinephrine.]
[D11AX01, minoxidil, Epinephrine may decrease the antihypertensive activities of Minoxidil.]
[N06BA12, lisdexamfetamine, The therapeutic efficacy of Lisdexamfetamine can be increased when used in combination with Epinephrine.]
[C01BD01, amiodarone, The metabolism of Amiodarone can be decreased when combined with Epinephrine.]
[N06AA09, amitriptyline, Amitriptyline may increase the vasopressor activities of Epinephrine.]
[L01EX03, pazopanib, The metabolism of Pazopanib can be decreased when combined with Epinephrine.]
[G04CA04, silodosin, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Silodosin.]
[N06AA17, amoxapine, Amoxapine may increase the vasopressor activities of Epinephrine.]
[N03AB05, fosphenytoin, The metabolism of Fosphenytoin can be decreased when combined with Epinephrine.]
[C07AA12, nadolol, Nadolol may decrease the bronchodilatory activities of Epinephrine.]
[S01GA01, naphazoline, The therapeutic efficacy of Naphazoline can be increased when used in combination with Epinephrine.]
[N06BA01, amphetamine, The therapeutic efficacy of Amphetamine can be increased when used in combination with Epinephrine.]
[M02AA12, naproxen, The metabolism of Naproxen can be decreased when combined with Epinephrine.]
[A10BG01, troglitazone, The therapeutic efficacy of Troglitazone can be decreased when used in combination with Epinephrine.]
[N06AX21, duloxetine, Duloxetine may increase the tachycardic activities of Epinephrine.]
[N04BX01, tolcapone, The metabolism of Epinephrine can be decreased when combined with Tolcapone.]
[L01CD02, docetaxel, The metabolism of Docetaxel can be decreased when combined with Epinephrine.]
[N01AH06, remifentanil, The risk or severity of hypertension can be increased when Epinephrine is combined with Remifentanil.]
[A10BX02, repaglinide, The therapeutic efficacy of Repaglinide can be decreased when used in combination with Epinephrine.]
[N05AX14, iloperidone, The metabolism of Iloperidone can be decreased when combined with Epinephrine.]
[N06AX23, desvenlafaxine, Desvenlafaxine may increase the tachycardic activities of Epinephrine.]
[C09CA07, telmisartan, Epinephrine may decrease the antihypertensive activities of Telmisartan.]
[N06AF02, nialamide, Nialamide may increase the hypertensive activities of Epinephrine.]
[C08CA04, nicardipine, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Nicardipine.]
[C04AE02, nicergoline, Nicergoline may increase the hypertensive and vasoconstricting activities of Epinephrine.]
[P02DA01, niclosamide, The metabolism of Niclosamide can be decreased when combined with Epinephrine.]
[N07BA01, nicotine, The serum concentration of Epinephrine can be increased when it is combined with Nicotine.]
[M02AA17, niflumic acid, The risk or severity of hypertension can be increased when Epinephrine is combined with Niflumic acid.]
[C08CA06, nimodipine, Epinephrine may decrease the antihypertensive activities of Nimodipine.]
[C08CA07, nisoldipine, Epinephrine may decrease the antihypertensive activities of Nisoldipine.]
[C08CA08, nitrendipine, Epinephrine may decrease the antihypertensive activities of Nitrendipine.]
[N04BC05, pramipexole, The serum concentration of Pramipexole can be increased when it is combined with Epinephrine.]
[C02DD01, nitroprusside, Epinephrine may decrease the antihypertensive activities of Nitroprusside.]
[N01AX13, nitrous oxide, Nitrous oxide may increase the arrhythmogenic activities of Epinephrine.]
[C01CA03, norepinephrine, The therapeutic efficacy of Epinephrine can be increased when used in combination with Norepinephrine.]
[G03DC02, norethindrone, The metabolism of Norethisterone can be decreased when combined with Epinephrine.]
[C02KX01, bosentan, The metabolism of Bosentan can be decreased when combined with Epinephrine.]
[N06AA10, nortriptyline, The metabolism of Nortriptyline can be decreased when combined with Epinephrine.]
[G02CA02, nylidrin, The therapeutic efficacy of Nylidrin can be increased when used in combination with Epinephrine.]
[A02BC01, omeprazole, The metabolism of Omeprazole can be decreased when combined with Epinephrine.]
[N06AA05, opipramol, Opipramol may increase the vasopressor activities of Epinephrine.]
[R03CB03, metaproterenol, The therapeutic efficacy of Orciprenaline can be increased when used in combination with Epinephrine.]
[G04CA02, tamsulosin, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Tamsulosin.]
[C01AC01, ouabain, The risk or severity of Cardiac Arrhythmia can be increased when Epinephrine is combined with Ouabain.]
[C07AA02, oxprenolol, Oxprenolol may decrease the bronchodilatory activities of Epinephrine.]
[C01DX03, oxyfedrine, The risk or severity of hypertension can be increased when Epinephrine is combined with Oxyfedrine.]
[S01GA04, oxymetazoline, The absorption of Epinephrine can be decreased when combined with Oxymetazoline.]
[S01BC02, oxyphenbutazone, The risk or severity of hypertension can be increased when Epinephrine is combined with Oxyphenbutazone.]
[A03AB03, oxyphenonium, The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Epinephrine.]
[H01BB02, oxytocin, The risk or severity of hypertension can be increased when Epinephrine is combined with Oxytocin.]
[V04CH30, 4-aminohippuric acid, The serum concentration of Epinephrine can be increased when it is combined with Aminohippuric acid.]
[N05AH05, asenapine, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Asenapine.]
[M03AC01, pancuronium, The risk or severity of adverse effects can be increased when Pancuronium is combined with Epinephrine.]
[H02AB05, paramethasone, The risk or severity of hypokalemia can be increased when Paramethasone is combined with Epinephrine.]
[C02KC01, pargyline, Pargyline may increase the hypertensive activities of Epinephrine.]
[G04BD11, fesoterodine, The risk or severity of Tachycardia can be increased when Epinephrine is combined with Fesoterodine.]
[C07AA23, penbutolol, Penbutolol may decrease the bronchodilatory activities of Epinephrine.]
[C04AD03, pentoxifylline, The risk or severity of adverse effects can be increased when Epinephrine is combined with Pentoxifylline.]
[N04BC02, pergolide, Pergolide may increase the hypertensive and vasoconstricting activities of Epinephrine.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Epinephrine.]
[N06AF03, phenelzine, Phenelzine may increase the hypertensive activities of Epinephrine.]
[A10BA01, phenformin, The therapeutic efficacy of Phenformin can be decreased when used in combination with Epinephrine.]
[R06AB05, pheniramine, The therapeutic efficacy of Epinephrine can be increased when used in combination with Pheniramine.]
[N03AA02, phenobarbital, The metabolism of Phenobarbital can be decreased when combined with Epinephrine.]
[C04AX02, phenoxybenzamine, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Phenoxybenzamine.]
[B01AA04, phenprocoumon, The metabolism of Phenprocoumon can be decreased when combined with Epinephrine.]
[A08AA01, phentermine, The therapeutic efficacy of Phentermine can be increased when used in combination with Epinephrine.]
[V03AB36, phentolamine, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Phentolamine.]
[M02AA01, phenylbutazone, The metabolism of Phenylbutazone can be decreased when combined with Epinephrine.]
[S01GA05, phenylephrine, The therapeutic efficacy of Phenylephrine can be increased when used in combination with Epinephrine.]
[R01BA01, phenylpropanolamine, The therapeutic efficacy of Phenylpropanolamine can be increased when used in combination with Epinephrine.]
[N03AB02, phenytoin, The metabolism of Phenytoin can be decreased when combined with Epinephrine.]
[L02BB03, bicalutamide, The metabolism of Bicalutamide can be decreased when combined with Epinephrine.]
[C08CX01, mibefradil, Epinephrine may decrease the antihypertensive activities of Mibefradil.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Epinephrine.]
[C07AA03, pindolol, Pindolol may decrease the bronchodilatory activities of Epinephrine.]
[C10AA05, atorvastatin, The metabolism of Atorvastatin can be decreased when combined with Epinephrine.]
[J05AE01, saquinavir, The risk or severity of adverse effects can be increased when Saquinavir is combined with Epinephrine.]
[C09CA02, eprosartan, Epinephrine may decrease the antihypertensive activities of Eprosartan.]
[A02BX03, pirenzepine, The risk or severity of Tachycardia can be increased when Epinephrine is combined with Pirenzepine.]
[S01BC06, piroxicam, The metabolism of Piroxicam can be decreased when combined with Epinephrine.]
[J01MA11, grepafloxacin, The serum concentration of Epinephrine can be increased when it is combined with Grepafloxacin.]
[N02CX01, pizotyline, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Pizotifen.]
[C09CA04, irbesartan, The metabolism of Irbesartan can be decreased when combined with Epinephrine.]
[A10BG02, rosiglitazone, The therapeutic efficacy of Rosiglitazone can be decreased when used in combination with Epinephrine.]
[A03AE01, alosetron, The metabolism of Alosetron can be decreased when combined with Epinephrine.]
[C03AA05, polythiazide, The risk or severity of hypokalemia can be increased when Epinephrine is combined with Polythiazide.]
[A10BH03, saxagliptin, The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Epinephrine.]
[V03AB21, potassium iodide, The risk or severity of adverse effects can be increased when Epinephrine is combined with Potassium Iodide.]
[A10AD04, insulin lispro, The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Epinephrine.]
[C10AA08, pitavastatin, The metabolism of Pitavastatin can be decreased when combined with Epinephrine.]
[C07AB01, practolol, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Practolol.]
[C02CA01, prazosin, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Prazosin.]
[S03BA02, prednisolone, The risk or severity of hypokalemia can be increased when Prednisolone is combined with Epinephrine.]
[H02AB07, prednisone, The risk or severity of hypokalemia can be increased when Prednisone is combined with Epinephrine.]
[R06AX05, antazoline, The therapeutic efficacy of Epinephrine can be increased when used in combination with Antazoline.]
[N03AA03, primidone, The metabolism of Primidone can be decreased when combined with Epinephrine.]
[M04AB01, probenecid, The serum concentration of Epinephrine can be increased when it is combined with Probenecid.]
[C01BA02, procainamide, The serum concentration of Procainamide can be increased when it is combined with Epinephrine.]
[S01HA05, procaine, Procaine may increase the hypertensive activities of Epinephrine.]
[L01XB01, procarbazine, Procarbazine may increase the hypertensive activities of Epinephrine.]
[C10AB05, fenofibrate, The metabolism of Fenofibrate can be decreased when combined with Epinephrine.]
[N04AA04, procyclidine, The risk or severity of Tachycardia can be increased when Procyclidine is combined with Epinephrine.]
[G03DA04, progesterone, The serum concentration of Epinephrine can be increased when it is combined with Progesterone.]
[N05AA03, promazine, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Promazine.]
[R06AD02, promethazine, Promethazine may decrease the vasoconstricting activities of Epinephrine.]
[C01BC03, propafenone, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Propafenone.]
[A03AB05, propantheline, The risk or severity of Tachycardia can be increased when Epinephrine is combined with Propantheline.]
[R06AX26, fexofenadine, The therapeutic efficacy of Epinephrine can be increased when used in combination with Fexofenadine.]
[N05AC01, periciazine, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Periciazine.]
[N05CM06, propiomazine, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Propiomazine.]
[L01XH02, romidepsin, The metabolism of Romidepsin can be decreased when combined with Epinephrine.]
[N01AX10, propofol, The metabolism of Propofol can be decreased when combined with Epinephrine.]
[C07AA05, propranolol, Propranolol may decrease the bronchodilatory activities of Epinephrine.]
[H03BA02, propylthiouracil, The risk or severity of adverse effects can be increased when Epinephrine is combined with Propylthiouracil.]
[C01AB01, proscillaridin, The risk or severity of Cardiac Arrhythmia can be increased when Epinephrine is combined with Proscillaridin.]
[N02CC04, rizatriptan, The risk or severity of hypertension can be increased when Epinephrine is combined with Rizatriptan.]
[B01AC09, epoprostenol, Epinephrine may decrease the antihypertensive activities of Epoprostenol.]
[R03DC03, montelukast, The metabolism of Montelukast can be decreased when combined with Epinephrine.]
[N06AA11, protriptyline, Protriptyline may increase the vasopressor activities of Epinephrine.]
[R01BA02, pseudoephedrine, The therapeutic efficacy of Pseudoephedrine can be increased when used in combination with Epinephrine.]
[N05AX12, aripiprazole, The metabolism of Aripiprazole can be decreased when combined with Epinephrine.]
[N07XX07, dalfampridine, The serum concentration of Dalfampridine can be increased when it is combined with Epinephrine.]
[A03AB15, diphemanil, The risk or severity of Tachycardia can be increased when Epinephrine is combined with Diphemanil.]
[A03AB09, isopropamide, The risk or severity of Tachycardia can be increased when Epinephrine is combined with Isopropamide.]
[S01FA03, methscopolamine, The risk or severity of Tachycardia can be increased when Epinephrine is combined with Methscopolamine.]
[R06AC01, pyrilamine, The therapeutic efficacy of Epinephrine can be increased when used in combination with Mepyramine.]
[P01AX05, quinacrine, The serum concentration of Epinephrine can be increased when it is combined with Quinacrine.]
[C01BA01, quinidine, The metabolism of Quinidine can be decreased when combined with Epinephrine.]
[P01BC01, quinine, The therapeutic efficacy of Quinine can be decreased when used in combination with Epinephrine.]
[A02BA02, ranitidine, The serum concentration of Ranitidine can be increased when it is combined with Epinephrine.]
[C02AA01, rescinnamine, Epinephrine may decrease the antihypertensive activities of Rescinnamine.]
[C02AA02, reserpine, The serum concentration of Reserpine can be increased when it is combined with Epinephrine.]
[R03AC05, rimiterol, The risk or severity of hypertension can be increased when Epinephrine is combined with Rimiterol.]
[G02CA01, ritodrine, The therapeutic efficacy of Ritodrine can be increased when used in combination with Epinephrine.]
[N02BA05, salicylamide, The risk or severity of hypertension can be increased when Epinephrine is combined with Salicylamide.]
[A07EC01, sulfasalazine, The risk or severity of hypertension can be increased when Epinephrine is combined with Sulfasalazine.]
[S01BC08, salicylic acid, The metabolism of Salicylic acid can be decreased when combined with Epinephrine.]
[S01FA02, scopolamine, The risk or severity of Tachycardia can be increased when Epinephrine is combined with Scopolamine.]
[N04BD01, selegiline, Selegiline may increase the hypertensive activities of Epinephrine.]
[C07AA07, sotalol, Sotalol may decrease the bronchodilatory activities of Epinephrine.]
[L01CD04, cabazitaxel, The metabolism of Cabazitaxel can be decreased when combined with Epinephrine.]
[C03DA01, spironolactone, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Spironolactone.]
[N03AG01, valproic acid, The metabolism of Valproic acid can be decreased when combined with Epinephrine.]
[D07AB02, hydrocortisone butyrate, The risk or severity of hypokalemia can be increased when Hydrocortisone butyrate is combined with Epinephrine.]
[H02CA04, levoketoconazole, The serum concentration of Epinephrine can be increased when it is combined with Levoketoconazole.]
[M01AE11, tiaprofenic acid, The risk or severity of hypertension can be increased when Epinephrine is combined with Tiaprofenic acid.]
[R03BB01, ipratropium bromide, The risk or severity of Tachycardia can be increased when Ipratropium is combined with Epinephrine.]
